Fig. 5From: Identification of PANoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinomaMolecular docking. Screening of candidate small molecules for target proteins using molecular docking. The figure shows the docking poses of the BAX active pocket with Allantoic Acid (A), Chalcomoracin (B), Nadide (C), and Triphosphopyridine Nucleotide (D). CASP1 active pocket with Biliverdin (E), Epicatechin ( F), Epigallocatechin (G), and Glutathione (H). docking poses of CASP8 active pocket with Abrine (I), Citrulline (J), Indicaxanthin (K), and Stachyose (L). docking poses of PYCARD active pocket with Heliosin (M), Laminaran (N), Nadide (O) and Oroxin B (P) in docking posesBack to article page